Literature DB >> 18594942

FXIIIA and TGF-beta over-expression produces normal musculo-skeletal phenotype in TG2-/- mice.

U Tarantino1, F Oliva, G Taurisano, A Orlandi, V Pietroni, E Candi, G Melino, N Maffulli.   

Abstract

Transglutaminase (TGs) enzymes and proteins crosslinking have for long time been implicated in the formation of hard tissue development, matrix maturation and mineralization. Among the TGs family members, in the context of connective tissue formation, TG2 and Factor XIII are expressed in cartilage by hypertrophic chondrocytes. Here, we analyse the morphological consequences of TG2 deficiency, during the development of skeletal elements. When TG2 is absent, there are not gross abnormalities in the development of the skeletal system, probably from compensatory mechanisms resulting in increased expression of FXIIIA and TGF-beta 1. In vivo other TGs may be involved in promoting chondrocytes and osteoblast differentiation and matrix mineralisation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18594942     DOI: 10.1007/s00726-008-0133-7

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  13 in total

Review 1.  Cellular functions of tissue transglutaminase.

Authors:  Maria V Nurminskaya; Alexey M Belkin
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

Review 2.  Transglutaminase regulation of cell function.

Authors:  Richard L Eckert; Mari T Kaartinen; Maria Nurminskaya; Alexey M Belkin; Gozde Colak; Gail V W Johnson; Kapil Mehta
Journal:  Physiol Rev       Date:  2014-04       Impact factor: 37.312

3.  Transglutaminase 2 regulates early chondrogenesis and glycosaminoglycan synthesis.

Authors:  Dmitry Nurminsky; Shobana Shanmugasundaram; Stephanie Deasey; Claire Michaud; Steven Allen; Doris Hendig; Akbar Dastjerdi; Philippa Francis-West; Maria Nurminskaya
Journal:  Mech Dev       Date:  2010-12-01       Impact factor: 1.882

4.  Transglutaminase-mediated oligomerization promotes osteoblast adhesive properties of osteopontin and bone sialoprotein.

Authors:  Jennifer Forsprecher; Zhemeng Wang; Harvey A Goldberg; Mari T Kaartinen
Journal:  Cell Adh Migr       Date:  2011-01-01       Impact factor: 3.405

5.  Clinical and biological aspects of rotator cuff tears.

Authors:  Alessio Giai Via; Mauro De Cupis; Marco Spoliti; Francesco Oliva
Journal:  Muscles Ligaments Tendons J       Date:  2013-07-09

6.  Characterization of the transglutaminase gene family in zebrafish and in vivo analysis of transglutaminase-dependent bone mineralization.

Authors:  Stephanie Deasey; Olga Grichenko; Shaojun Du; Maria Nurminskaya
Journal:  Amino Acids       Date:  2011-08-02       Impact factor: 3.520

7.  Transglutaminases factor XIII-A and TG2 regulate resorption, adipogenesis and plasma fibronectin homeostasis in bone and bone marrow.

Authors:  Aisha Mousa; Cui Cui; Aimei Song; Vamsee D Myneni; Huifang Sun; Jin Jin Li; Monzur Murshed; Gerry Melino; Mari T Kaartinen
Journal:  Cell Death Differ       Date:  2017-04-07       Impact factor: 15.828

Review 8.  Transglutaminse 2 and EGGL, the protein cross-link formed by transglutaminse 2, as therapeutic targets for disabilities of old age.

Authors:  William Bains
Journal:  Rejuvenation Res       Date:  2013-12       Impact factor: 4.663

9.  Cellular Factor XIIIA Transglutaminase Localizes in Caveolae and Regulates Caveolin-1 Phosphorylation, Homo-oligomerization and c-Src Signaling in Osteoblasts.

Authors:  Shuai Wang; Mari T Kaartinen
Journal:  J Histochem Cytochem       Date:  2015-07-31       Impact factor: 2.479

10.  Plasma membrane factor XIIIA transglutaminase activity regulates osteoblast matrix secretion and deposition by affecting microtubule dynamics.

Authors:  Hadil F Al-Jallad; Vamsee D Myneni; Sarah A Piercy-Kotb; Nicolas Chabot; Amina Mulani; Jeffrey W Keillor; Mari T Kaartinen
Journal:  PLoS One       Date:  2011-01-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.